June 19, 2025

Fair Isaac Corporation (FICO) Stock Analysis: A 24.55% Potential Upside Amidst Strong Revenue Growth

Fair Isaac Corporation (NYSE: FICO), a stalwart in the technology sector, continues to capture investor attention with its robust revenue growth and substantial market cap of $42.93 billion. As a..

Viemed Healthcare, Inc. (VMD) Stock Analysis: A Promising 78% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Viemed Healthcare, Inc. (NASDAQ: VMD) presents a compelling case. Specializing in post-acute respiratory healthcare and home medical equipment, Viemed is strategically positioned..

Neurogene Inc. (NGNE) Investor Outlook: Evaluating a 139% Potential Upside in Biotech Innovation

Neurogene Inc. (NGNE), a burgeoning player in the biotechnology sector, is capturing the interest of individual investors with its innovative approach to treating rare neurological diseases. With a market capitalization..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a 157.78% Potential Upside in Healthcare Innovation

ClearPoint Neuro Inc. (NASDAQ: CLPT), a pioneering force in the healthcare sector, stands at the forefront of medical innovation with a focus on developing cutting-edge platforms for minimally invasive surgical..

Vimeo, Inc. (VMEO) Stock Analysis: Exploring a 69% Potential Upside for Investors

Vimeo, Inc. (NASDAQ: VMEO), a prominent player in the technology sector, provides innovative video software solutions that cater to a diverse clientele ranging from small businesses to large enterprises. Headquartered..

Fulcrum Therapeutics, Inc. (FULC): Investor Outlook on a Promising Biotech with 19% Upside Potential

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is making waves in the biotechnology sector, captivating investor interest with its innovative approach to addressing genetically defined diseases. As a clinical-stage biopharmaceutical company, Fulcrum..

UroGen Pharma Ltd. (URGN) Investor Outlook: Analyzing the 131% Potential Upside

UroGen Pharma Ltd. (NASDAQ: URGN) has captured the attention of investors with its robust potential upside, as evidenced by a striking 131.17% when comparing the current stock price to the..

Immutep Limited (IMMP) Stock Analysis: Exploring a Potential 490% Upside in the Biotech Sector

Immutep Limited (NASDAQ: IMMP), an Australian biotechnology firm, has caught the attention of investors with its significant potential upside of 490.06%. Specializing in pioneering immunotherapies targeting LAG-3, Immutep’s focus on..

AudioEye, Inc. (AEYE) Stock Analysis: A Small Cap Tech Player with a 92% Upside Potential

AudioEye, Inc. (NASDAQ: AEYE), a dynamic player in the technology sector, presents a compelling investment opportunity with a potential upside of 92.11%, according to recent analyst ratings. This Tucson, Arizona-based..

Canopy Growth Corporation (CGC) Stock Analysis: Evaluating the 78.81% Potential Upside

For investors keeping an eye on the healthcare sector, particularly within the burgeoning cannabis industry, Canopy Growth Corporation (CGC) presents an intriguing, albeit risky, opportunity. Operating out of Smiths Falls,..

Rigel Pharmaceuticals (RIGL) Stock Analysis: Unpacking the 74% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) has captured the attention of the biotech investment community with a potential upside of 74.29%, positioning it as a compelling opportunity in the healthcare sector...

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring a Potential 191.61% Upside in the Biotechnology Sector

Entrada Therapeutics, Inc. (NASDAQ: TRDA), a burgeoning name in the biotechnology industry, has been capturing the attention of investors with its groundbreaking approach to treating neuromuscular diseases. Headquartered in Boston,..

iTeos Therapeutics, Inc. (ITOS) Stock Analysis: A Biotech Play with 10% Upside Potential

iTeos Therapeutics, Inc. (NASDAQ: ITOS) is a clinical-stage biopharmaceutical company that has caught the attention of investors seeking opportunities within the healthcare sector, specifically the biotechnology industry. With a market..

Absci Corporation (ABSI) Stock Analysis: Unveiling a 231.82% Potential Upside in AI-Driven Biotechnology

Absci Corporation (NASDAQ: ABSI) stands at the intersection of healthcare and cutting-edge technology, making waves in the biotechnology sector with its innovative approach to drug creation. Based in Vancouver, Washington,..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Uncovering a 13.67% Upside in a Challenging Market

ZoomInfo Technologies Inc. (NASDAQ: GTM), a key player in the Software – Application industry, continues to capture investor attention with its comprehensive go-to-market intelligence platform. Despite facing headwinds, ZoomInfo’s stock..

A2Z Cust2Mate Solutions Corp. (AZ) Stock Analysis: Is a 91.75% Upside Within Reach?

Investors are casting a keen eye on A2Z Cust2Mate Solutions Corp. (AZ), a Canadian technology firm that is making waves with its innovative retail solutions. The company’s flagship offering, the..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating Market Challenges with Strategic Insights

Zhengye Biotechnology Holding Limited (ZYBT), a key player in the healthcare sector focusing on the development and manufacture of veterinary vaccines, presents an intriguing case for investors looking to explore..

Varex Imaging Corporation (VREX) Investor Outlook: A Healthcare Stock with Over 116% Potential Upside

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector’s medical devices industry, presents a compelling case for investors with its substantial potential upside of over 116%. Headquartered..

Tvardi Therapeutics, Inc. (TVRD): Investor Outlook on a Biotech Challenger with 119% Potential Upside

Tvardi Therapeutics, Inc. (TVRD) is a name that is capturing the attention of investors in the biotechnology sector, particularly those with an appetite for high-reward opportunities. With a market capitalization..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring the 258.80% Potential Upside

Investors with an eye on the biotechnology sector may find aTyr Pharma, Inc. (NASDAQ: ATYR) an intriguing proposition. This San Diego-based clinical-stage biotech company is pioneering therapies aimed at treating..

Search

Funds

June 19, 2025

Search

Funds

June 19, 2025

FTSE 100

Funds